165 related articles for article (PubMed ID: 29090302)
21. Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents.
Relaño-Rodríguez I; Espinar-Buitrago MS; Martín-Cañadilla V; Gómez-Ramirez R; Jiménez JL; Muñoz-Fernández MA
J Nanobiotechnology; 2021 Mar; 19(1):65. PubMed ID: 33658029
[TBL] [Abstract][Full Text] [Related]
22. In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa.
Villegas G; Calenda G; Zhang S; Mizenina O; Kleinbeck K; Cooney ML; Hoesley CJ; Creasy GW; Friedland B; Fernández-Romero JA; Zydowsky TM; Teleshova N
Antimicrob Agents Chemother; 2016 Sep; 60(9):5459-66. PubMed ID: 27381393
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
[TBL] [Abstract][Full Text] [Related]
24. Antiviral potential and mode of action of Indigofera heterantha against HSV-2 by targeting the early stages of infection.
Kaushik NK; Guha R; Thomas BM
Antivir Ther; 2017; 22(5):381-391. PubMed ID: 28008866
[TBL] [Abstract][Full Text] [Related]
25. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.
Kesharwani A; Polachira SK; Nair R; Agarwal A; Mishra NN; Gupta SK
BMC Complement Altern Med; 2017 Feb; 17(1):110. PubMed ID: 28196487
[TBL] [Abstract][Full Text] [Related]
26. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
[TBL] [Abstract][Full Text] [Related]
27. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
Celum CL; Robinson NJ; Cohen MS
J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220
[TBL] [Abstract][Full Text] [Related]
28. Anti-Human Immunodeficiency Virus Activity of Thiol-Ene Carbosilane Dendrimers and Their Potential Development as a Topical Microbicide.
Sánchez-Rodríguez J; Díaz L; Galán M; Maly M; Gómez R; Javier de la Mata F; Jiménez JL; Muñoz-Fernández MA
J Biomed Nanotechnol; 2015 Oct; 11(10):1783-98. PubMed ID: 26502641
[TBL] [Abstract][Full Text] [Related]
29. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484
[TBL] [Abstract][Full Text] [Related]
30. High Preventive Effect of G2-S16 Anionic Carbosilane Dendrimer against Sexually Transmitted HSV-2 Infection.
Rodriguez-Izquierdo I; Gasco S; Muñoz-Fernández MA
Molecules; 2020 Jun; 25(13):. PubMed ID: 32605185
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.
Luganini A; Nicoletto SF; Pizzuto L; Pirri G; Giuliani A; Landolfo S; Gribaudo G
Antimicrob Agents Chemother; 2011 Jul; 55(7):3231-9. PubMed ID: 21576438
[TBL] [Abstract][Full Text] [Related]
32. New anionic poly(alkylideneamine) dendrimers as microbicide agents against HIV-1 infection.
Maciel D; Guerrero-Beltrán C; Ceña-Diez R; Tomás H; Muñoz-Fernández MÁ; Rodrigues J
Nanoscale; 2019 May; 11(19):9679-9690. PubMed ID: 31066407
[TBL] [Abstract][Full Text] [Related]
33. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
[TBL] [Abstract][Full Text] [Related]
34. Extracts of Equisetum giganteum L and Copaifera reticulate Ducke show strong antiviral activity against the sexually transmitted pathogen herpes simplex virus type 2.
Churqui MP; Lind L; Thörn K; Svensson A; Savolainen O; Aranda KT; Eriksson K
J Ethnopharmacol; 2018 Jan; 210():192-197. PubMed ID: 28807852
[TBL] [Abstract][Full Text] [Related]
35. Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.
Tintori C; Iovenitti G; Ceresola ER; Ferrarese R; Zamperini C; Brai A; Poli G; Dreassi E; Cagno V; Lembo D; Canducci F; Botta M
PLoS One; 2018; 13(6):e0198478. PubMed ID: 29870553
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection.
García-Broncano P; Ceña-Diez R; de la Mata FJ; Gómez R; Resino S; Muñoz-Fernández MÁ
Eur J Pharmacol; 2017 Sep; 811():155-163. PubMed ID: 28577966
[TBL] [Abstract][Full Text] [Related]
37. Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro.
Córdoba EV; Arnáiz E; De La Mata FJ; Gómez R; Leal M; Pion M; Muñoz-Fernández MA
AIDS; 2013 Aug; 27(13):2053-8. PubMed ID: 23612005
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.
Wang A; Chen F; Wang Y; Shen M; Xu Y; Hu J; Wang S; Geng F; Wang C; Ran X; Su Y; Cheng T; Wang J
J Virol; 2013 Mar; 87(5):2835-45. PubMed ID: 23269800
[TBL] [Abstract][Full Text] [Related]
39. Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro.
Dai W; Wu Y; Bi J; Wang J; Wang S; Kong W; Barbier J; Cintrat JC; Gao F; Jiang Z; Gillet D; Su W; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):849-859. PubMed ID: 29847864
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
